Acadia Pharmaceuticals | L'Utile Ante Imposte



Pre Tax Profit Cambiamento Data
Acadia Pharmaceuticals USD 161.08M 122.28M 2024-12
ALKERMES USD 443.75M 333.52M 2024-12
Alnylam Pharmaceuticals USD -193958000 85.3M 2024-12
Biogen USD 572.2M 118.5M 2024-12
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Bristol-Myers Squibb USD 4.26B 226M 2024-12
Corcept Therapeutics USD 161.49M 108.55M 2024-12
Cytokinetics USD -150020000 10.52M 2024-12
Eisai JPY 29.55B 13.99B 2024-12
Eli Lilly USD 5.54B 3.83B 2024-12
Incyte USD 406.83M 147.12M 2024-12
J&J USD 5.42B 1.86B 2024-12
Moderna USD -1184000000 1.2B 2024-12
Neurocrine Biosciences USD 162.6M 27.7M 2024-12
Pfizer USD 4.44B 2.36B 2024-12
Prothena USD -59501000 335K 2024-12
PTC Therapeutics USD -94699000 3.29M 2024-12
Sarepta Therapeutics USD 171.74M 137.74M 2024-12
Ultragenyx Pharmaceutical USD -133404000 191K 2024-12
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12



Acadia Pharmaceuticals L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.